#eye disease
Related Stories (3)
Merck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition - Reuters
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition Reuters
August 6, 2026US FDA approves Outlook Therapeutics' eye disease drug - Reuters
US FDA approves Outlook Therapeutics' eye disease drug Reuters
July 24, 2026Related Pages (3)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa